Juli Stover Joins eVisit As New Chief Strategy Officer

Telemedicine and healthcare technology expert Stover joins eVisit's C-suite to oversee strategic initiatives aimed at spurring company growth

Juli Stover: eVisit, the leading Virtual Care platform for large healthcare providers, today announced that Juli Stover has joined its leadership team as Chief Strategy Officer. Stover most recently served as Vice President of Virtual Health Strategies at Envision Healthcare, a national hospital-based physician group headquartered in Nashville.

Juli Stover will oversee eVisit’s growth initiatives by contributing to the product roadmap based on customer and market trends, as well as securing strategic partnerships. Stover joins just after eVisit announced its closure of a $45 million Series B financing round led by the Growth Equity business within Goldman Sachs Asset Management.

Prior to her time at Envision, Juli Stover served as Vice President of Healthcare Alliances at Vidyo, a software-based technology platform located in Hackensack, New Jersey. In that role, Stover developed strategic partnerships to drive organizational growth while also collaborating on partner enablement plans to scale adoption.

Stover’s other leadership roles included Vice President of Telehealth and Innovative Health Solutions at Corizon Health, multiple leadership positions at InTouch Health (now part of Teladoc), and HCA Healthcare.

“I’m thrilled to be joining eVisit at a pivotal time when patients and clinicians alike have come to value and rely on the model of virtual care,” said Stover. “I’ve been working in the healthcare industry for many years and view this new role as an opportunity to advance patient care through telehealth and data analytics.”

Stover attended Auburn University and graduated from Troy University with a Bachelor of Science degree in Human Services and Marketing.

“We are excited to welcome Juli Stover to eVisit’s C-suite,” said Bret Larsen, CEO of eVisit. “Her robust healthcare experience means she is exactly the caliber of talent we need to support our customers and advance our vision for the future of healthcare. As we head into 2022, we are eager to add Juli’s expertise to eVisit’s incredible momentum.”

SourceeVisit

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.